Tag: Eric Duncavage May 10, 2024 Duncavage named director of new division in pathology & immunologyRecognized for contributions to Medicare-approved whole-genome tests .News Release February 22, 2024 Medicare approves genetic test for solid tumorsTest can quickly identify treatable cancer mutations, guide precision therapy.News Release August 17, 2023 Medicare approves WashU Medicine’s whole-genome test for blood cancersComplete picture of genetic errors can advance precision medicine approaches to treatment.News Release April 9, 2021 Genomic testing services in pathology & immunology department to be expandedChanges aimed at improving diagnosis of cancer, inherited diseases.News Release March 10, 2021 Promising role for whole genome sequencing in guiding blood cancer treatmentSequencing results returned in a few days; costs similar to conventional testing.News Release February 20, 2019 Clinical Research Forum recognizes top studiesOncologists show way to ID patients at high risk of cancer recurrence. September 12, 2018 Genetic testing helps predict disease recurrence in myelodysplastic syndromeLikelihood of recurrence high if mutations detectable after stem cell transplant.News Release Posts navigation
